Share

Osteoporosis Drug May Benefit Heart Health

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. The association was seen for up to 10 years after fracture. In the study, patients newly diagnosed with hip fracture from 2005 through 2013...
Share

Researchers Compare Health Status, Rates of Cardiometabolic Disease Between Transgender Adults and Cisgender Adults

Significant differences in health status and cardiometabolic health exist between transgender adults and cisgender adults in the United States, according to a study recently published in the Journal of the Endocrine Society. Researchers led by Natalie J. Nokoff, MD, of the University of Colorado Denver Anschutz Medical Campus in Aurora, point out that 0.5 percent...
Share

Researchers Suggest Possible Biomarker for Diabetic Cardiomyopathy

Alterations in the myocardial ghrelin-GHSR1a system may predict diabetic cardiomyopathy (DCM), according to a study recently published in the Journal of the Endocrine Society. Researchers led by Savita Dhanvantari, PhD, of the Lawson Health Research Institute in London, Ontario point out that DCM is characterized by progressive cardiac dysfunction, and that the early stages of...
Share

Yoga Benefits Patients with Metabolic Syndrome

One year of yoga training decreased pro-inflammatory adipokines and increased an anti-inflammatory adipokine in adults with metabolic syndrome and high-normal blood pressure, according to a study recently published in the Scandinavian Journal of Medicine & Science in Sports. Researchers led by Parco Siu, of the University of Hong Kong, point out that lifestyle modification is...
Share

Canagliflozin Significantly Reduces the Risk of Heart Failure-Related Outcomes in Type 2 Diabetes Patients at Risk for or With a History of Cardiovascular Disease

Late-breaking exploratory analysis from the CANVAS Program presented at the American College of Cardiology’s 67th Annual Scientific Session The results of  recent analysis showed that canagliflozin significantly reduced the risk of cardiovascular (CV) death or hospitalization for heart failure (HHF) in patients with type 2 diabetes (T2D) at high CV risk. This exploratory analysis from...
Share

Research Finds Little Difference Among Diet Plans’ Long-Term Effectiveness

Endocrine Society’s Scientific Statement examines challenges of managing obesity Whether you pick low-carb, low fat or another diet plan, scientific research indicates each can help some people achieve modest long-term weight loss with potential improvement in health risks, according to the Scientific Statement the Endocrine Society issued today on managing obesity. The authors found the...
Share

Young Hearts Run Free

YoungHearts_586279172 A new study shows that heavier adolescents may have an increased risk of succumbing to a cardiovascular event death in middle age. What can be done earlier in life to forestall these events and should researchers take another look at what constitutes an ideal body mass index for kids? February is American Heart Month and...